Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 8/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.37 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.37 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.37 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.36 |
| ▸ | TRAP1 | Q12931 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CLPP | Q16740 | 1/20 | 0.35 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4746032 | 0.81 | P2RX7 (0.39) | P2RX7KDM4ESMN1; SMN2AKR1B1AKR1B10 | |
| SCHEMBL4518262 | 0.77 | AKR1B1 (0.45) | KDM4ESMN1; SMN2AKR1B1AKR1B10AKR1A1 | |
| SCHEMBL4221275 | 0.73 | KDM4E (0.40) | P2RX7KDM4ESMN1; SMN2AKR1B1CHRM1 | |
| SCHEMBL4746488 | 0.72 | HSD11B1 (0.39) | — | |
| SCHEMBL4746487 | 0.72 | HSD11B1 (0.39) | — | |
| SCHEMBL2028436 | 0.72 | BDKRB1 (0.58) | KDM4ESMN1; SMN2CHRM1BDKRB1 | |
| SCHEMBL29303350 | 0.72 | CHRM5 (0.52) | AKR1B1HSP90B1TRAP1CHRM1BDKRB1 | |
| SCHEMBL32686443 | 0.71 | PARK7 (0.50) | — | |
| SCHEMBL4518252 | 0.65 | AKR1B1 (0.48) | AKR1B1AKR1B10AKR1A1 | |
| SCHEMBL5256758 | 0.65 | KDM4E (0.46) | P2RX7KDM4ESMN1; SMN2CLPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008124518-A1 | OXO-DIHYDROISOINDOLE SULFONAMIDE COMPOUNDS AS MODULATORS OF THE CCK2 RECEPTOR | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-10-16 | — | — | WO | claimed |
| WO-2008124518-A1 | OXO-DIHYDROISOINDOLE SULFONAMIDE COMPOUNDS AS MODULATORS OF THE CCK2 RECEPTOR | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-10-16 | — | — | WO | disclosed |